Direct-To-Consumer (DTC) Laboratory Testing Market Report 2026

Direct-To-Consumer (DTC) Laboratory Testing Market Overview

• Direct-To-Consumer (DTC) Laboratory Testing market size has reached to $5.78 billion in 2025 • Expected to grow to $18.4 billion in 2030 at a compound annual growth rate (CAGR) of 25.1% • Growth Driver: Rising Prevalence Of Infectious Diseases Fueling The Growth Of The Market Due To Increased Need For Accessible Diagnostics • Market Trend: Transforming At-Home Laboratory Testing With Convenient Phlebotomy Services • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Direct-To-Consumer (DTC) Laboratory Testing Market?

Direct-to-consumer (DTC) laboratory testing refers to a model where individuals order medical tests and receive their results directly, without necessarily involving a healthcare provider or traditional healthcare system intermediaries. It involves online platforms or services where consumers can select from various available tests, order them, provide a specimen at home or a designated collection site, and then receive the results electronically. The main samples of direct-to-consumer (DTC) laboratory testing are blood, urine, saliva, and others. Blood samples refer to small amounts of blood collected for medical testing or analysis. The test includes genetic testing, disease risk assessment testing, complete blood count (CBC), diabetes testing, thyroid-stimulating hormone (TSH) testing, and others for applications such as diagnostics, research and development, drug discovery and development used by end users including hospitals, clinics, specialty labs, and diagnostic centers.

What Is The Direct-To-Consumer (DTC) Laboratory Testing Market Growth Forecast?

The direct-to-consumer (dtc) laboratory testing market size is expected to see exponential growth in the next few years. It will grow to $18.4 billion in 2030 at a compound annual growth rate (CAGR) of 25.1%. The growth in the forecast period can be attributed to automation of laboratory workflows, ai-based diagnostics, expansion of home sample collection, regulatory acceptance, personalized health monitoring. Major trends in the forecast period include increasing adoption of at-home diagnostic testing, expansion of online test ordering platforms, growth of preventive health screening services, rising consumer demand for rapid test results, integration of digital result delivery systems.

Global Direct-To-Consumer (DTC) Laboratory Testing Market Segmentation

1) By Sample Type: Blood, Urine, Saliva, Other Sample Types 2) By Test Type: Genetic Testing, Disease Risk Assessment Testing, Complete Blood Count (CBC), Diabetes Testing, Thyroid-Stimulating Hormone (TSH) Testing, Other Test Types 3) By Application: Diagnostics, Research And Development, Drug Discovery And Development 4) By End User: Hospitals, Clinics, Specialty Labs, Diagnostic Centers Subsegments: 1) By Blood: Blood Glucose, Cholesterol, Complete Blood Count (CBC), Blood Type, Vitamin and Mineral Levels, Hormone Levels, Liver And Kidney Function Tests 2) By Urine: Pregnancy Tests, Urinalysis, Kidney Function Tests, Drug And Alcohol Testing, UTI (Urinary Tract Infection) Screening, Hormone Tests 3) By Saliva: Hormone Testing, DNA Testing (Ancestry, Genetic Health Risks), Cortisol And Stress Level Tests, Food Sensitivity And Allergy Testing 4) By Other Sample Types: Stool, Hair, Breath

What Is The Driver Of The Direct-To-Consumer (DTC) Laboratory Testing Market?

The rising prevalence of infectious diseases is expected to propel the growth of the direct-to-consumer (DTC) laboratory testing market going forward. Infectious diseases refer to illnesses caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi transmitted from person to person through direct contact, indirect contact, or vectors such as insects or animals. The prevalence of infectious diseases is influenced by a complex interplay of biological, environmental, social, and economic factors. DTC laboratory testing contributes to preventing, detecting, and managing infectious diseases by increasing access to testing, promoting early intervention, and supporting public health efforts through data collection and education. For instance, in October 2024, according to the World Health Organization, a Switzerland-based international public health organization, approximately 8.2 million people were newly diagnosed with tuberculosis in 2023, up from about 7.5 million in 2022, placing tuberculosis as the leading infectious disease killer. Therefore, the rising prevalence of infectious diseases is driving the direct-to-consumer (DTC) laboratory testing industry.

Key Players In The Global Direct-To-Consumer (DTC) Laboratory Testing Market

Major companies operating in the direct-to-consumer (dtc) laboratory testing market are Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, PerkinElmer Inc, Genesis Healthcare Co., Natera Inc, Sonora Quest Laboratories, Ancestry.com LLC, 23andMe Holding Co, Thorne HealthTech Inc, Metropolis Healthcare Limited, Color Health Inc, LetsGetChecked Inc., MyHeritage Ltd, Everlywell Inc, Complete Genomics Incorporated, DanteLabs Inc, Gene by Gene Ltd., Veritas Intercontinental, DirectLabs LLC., WellnessFX Inc, Ulta Lab Tests LLC, Any Lab Test Now Inc, Vitagene Inc.

Global Direct-To-Consumer (DTC) Laboratory Testing Market Trends and Insights

Major companies operating in the direct-to-consumer (DTC) laboratory testing market are focused on developing innovative solutions, such as mobile phlebotomy services, to enhance convenience and accessibility for their customers. A mobile phlebotomy service is a healthcare service that brings blood collection (phlebotomy) to the patient's location, typically their home or workplace, rather than requiring the patient to visit a medical facility for blood tests. For instance, in July 2023, Quest Diagnostics Incorporated., a US-based company that provides diagnostic testing, information, and services, launched the Quest Mobile, a new service designed to streamline the process of specimen collection for laboratory testing across the nation. Quest Mobile helps patients effortlessly schedule appointments for at-home specimen collection by skilled phlebotomists. This convenient option enables patients to undergo a diverse array of laboratory tests from the comfort of their own homes, ensuring ease and accessibility in the testing process.

What Are Latest Mergers And Acquisitions In The Direct-To-Consumer (DTC) Laboratory Testing Market?

In May 2023, Getlabs, a US-based provider of at-home diagnostic collections, partnered with Nice Healthcare. This strategic partnership aims to streamline access to in-home healthcare services and lab testing, improving the overall healthcare experience for individuals through collaborative strengths. Nice Healthcare is a US-based provider of in-home and virtual primary care services.

Regional Outlook

North America was the largest region in the direct-to-consumer (DTC) laboratory testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Direct-To-Consumer (DTC) Laboratory Testing Market?

The direct-to-consumer (DTC) laboratory testing market consists of revenues earned by entities by provide services such as accessibility, convenience, wellness screening, genetic testing, health monitoring, nutritional analysis, fitness and performance testing, ancestry testing, maternity testing, pharmacogenomics testing, and nutrigenomics testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The direct-to-consumer (DTC) laboratory testing market also includes sales of home test kits, sample collection kits, point-of-care testing devices, sequencing kits, automated liquid handling systems, thermal cyclers, sterile swabs, wearable devices, and mobile apps or online platforms. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Direct-To-Consumer (DTC) Laboratory Testing Market Report 2026?

The direct-to-consumer (dtc) laboratory testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the direct-to-consumer (dtc) laboratory testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.